Vitamin K2 Supplement Guide 2026: MK-7 vs MK-4, Dose and Warfarin

Affiliate links: as an Amazon Associate and through other programs, we earn from qualifying purchases, at no extra cost to you. Learn more.

Reviewed October 20268 min readEvidence-basedBy Víctor, founder · How we work

Quick answer: If you take warfarin or a similar blood thinner, do not start vitamin K2 without your doctor: vitamin K changes how these drugs work, and as little as 10 mcg of MK-7 a day shifted clotting test results in some people. Adults need 90 mcg (women) or 120 mcg (men) of vitamin K a day from all forms, and most US diets provide that. The evidence that K2 supplements protect bones or arteries is limited and mixed.

Warfarin and Vitamin K2: Talk to Your Doctor First

Warfarin and similar anticoagulants work by blocking vitamin K. The NIH says vitamin K can have a serious and potentially dangerous interaction with these drugs, and that people who take them need to keep their vitamin K intake from food and supplements steady, because sudden changes can raise or lower the drug’s effect (NIH ODS).

Small amounts matter. In a study of 18 healthy adults given a drug that works like warfarin, MK-7 at 10 mcg a day lowered the INR (a clotting test) to a clinically relevant degree in at least 40% of them, and 20 mcg a day did so in at least 60%. The authors concluded that people on these drugs should avoid MK-7 supplements (Theuwissen et al., 2013). An earlier study warned that 50 mcg or more of MK-7 a day may interfere with anticoagulant treatment (Schurgers et al., 2007).

🆕 Free Download

Get our free supplement cheat sheet.

One page: typical doses, timing and upper limits for ten well-studied supplements. No upsell.

🔒 No spam. Unsubscribe anytime. We send 1-2 emails/month max.

Important: if you take a K2 supplement and are starting warfarin, or already take warfarin and are thinking about K2, tell the doctor or clinic that manages your INR. Do not start or stop K2 on your own.

Some other medicines can lower vitamin K levels, including antibiotics, bile acid sequestrants such as cholestyramine (used to lower cholesterol) and orlistat (NIH ODS).

How Much Vitamin K You Need and Where It Comes From

Vitamin K comes in two main natural forms. Vitamin K1 (phylloquinone) comes mostly from green leafy vegetables, vegetable oils and some fruits, and it is the main form in the diet. Vitamin K2 (menaquinones, such as MK-4 and MK-7) is found in some fermented foods and in modest amounts in meat, dairy foods and eggs (NIH ODS).

The adequate intake is 90 mcg a day for women and 120 mcg a day for men, counting all forms of vitamin K together. Most people in the United States get enough from their diet. There is no upper limit, because no harm from vitamin K in food or supplements has been reported (NIH ODS).

MK-4 vs MK-7

MK-4 and MK-7 are both forms of vitamin K2, but the body handles them differently. In healthy volunteers, MK-7 and K1 were both well absorbed, but MK-7 had a much longer half-life and built up to 7 to 8 times higher levels with daily use (Schurgers et al., 2007).

In healthy Japanese women, a single 420 mcg dose of MK-7 peaked in the blood after 6 hours and was still detectable 48 hours later, while the same dose of MK-4 could not be detected at all. Taking 60 mcg a day for a week raised blood MK-7 in everyone but did not raise MK-4 (Sato et al., 2012).

QuestionMK-4MK-7
Blood levels after one 420 mcg doseNot detectablePeak at 6 hours, detectable up to 48 hours
60 mcg a day for 7 daysNo rise in blood levelsBlood levels rose in everyone
Bone trialsJapanese fracture trialsOne 3-year trial of 180 mcg a day in 244 women
With warfarinAll vitamin K can interact; ask firstAs little as 10 mcg a day changed INR

The table draws on the bone trials described in the next section (Cockayne et al., 2006; Knapen et al., 2013) and on the warfarin data above (Theuwissen et al., 2013; NIH ODS). Higher blood levels do not by themselves mean better bones or arteries. Our D3 and K2 product comparison lists which form each product contains.

Bones: What the K2 Trials Found

A 3-year MK-7 trial gave 180 mcg a day or placebo to 244 healthy postmenopausal women. MK-7 slowed the age-related loss of bone mineral density at the lower spine and the femoral neck, but not at the total hip (Knapen et al., 2013).

An older meta-analysis found that all 7 trials that reported fractures were done in Japan and used MK-4, and those trials showed fewer fractures (Cockayne et al., 2006). A 2019 review of 36 trials was more cautious: in postmenopausal women and people with osteoporosis, vitamin K did not clearly change bone density or spine fractures. It may lower clinical fractures, but that result was no longer statistically significant when only trials at low risk of bias were counted, and the authors called the evidence insufficient (Mott et al., 2019).

The NIH says it is not clear whether vitamin K supplements affect the risk of osteoporosis, and that getting enough calcium and vitamin D, especially earlier in life, is important for bone mass (NIH ODS).

Arteries: What the Calcification Trials Found

The idea behind K2 for arteries is that a vitamin K-dependent protein (matrix Gla protein) may help limit abnormal calcium deposits in blood vessels. Observational studies linked higher K2 intake with less arterial calcification, but the NIH says the results of clinical trials have been inconclusive (NIH ODS).

In a 2-year trial in 365 men with an average age of 71 and calcium in the aortic valve, 720 mcg of MK-7 plus vitamin D a day did not slow valve calcification, and calcification of the aorta and coronary arteries was no different from placebo (Diederichsen et al., 2022).

In a 2-year trial in people with coronary artery disease (85 took MK-7 and 82 placebo), 360 mcg of MK-7 a day was linked to a smaller rise in coronary calcium scores than placebo (median 135 to 184, versus 145 to 214). The authors said the clinical meaning is still unknown, and no significant side effects were seen. The Dutch Heart Foundation funded the trial, and an MK-7 maker supplied the tablets for free (Vossen et al., 2026).

A 2023 meta-analysis of 14 trials (1,533 patients) found that vitamin K slightly slowed the rise in coronary calcium scores and called for better-designed trials (Li et al., 2023). A slower rise in calcium on a scan is not the same as fewer heart attacks, and none of these trials showed fewer heart attacks, strokes or deaths.

TrialPeopleDose and lengthResult
Bone density (2013)244 postmenopausal women180 mcg MK-7 a day, 3 yearsSlower bone loss at spine and femoral neck, not total hip
Aortic valve calcium (2022)365 older men720 mcg MK-7 plus vitamin D a day, 2 yearsNo difference from placebo
Coronary calcium (2026)167 people with coronary artery disease360 mcg MK-7 a day, 2 yearsSmaller rise in calcium score; clinical meaning unknown
Meta-analysis (2023)1,533 patients in 14 trialsDifferent doses and formsSlightly slower rise in coronary calcium score
What this means: K2 has not been shown to lower the risk of fractures or heart attacks, and no trial has shown that it removes calcium from arteries.

Frequently Asked Questions

Can I take vitamin K2 if I am on warfarin?

Only if your doctor agrees and monitors you. Vitamin K changes how warfarin works, and as little as 10 mcg of MK-7 a day lowered clotting test results in some people on a similar drug (NIH ODS; Theuwissen et al., 2013).

Is MK-7 better than MK-4?

MK-7 stays in the blood much longer and raised blood levels at a dose where MK-4 did not (Schurgers et al., 2007; Sato et al., 2012). Whether that leads to better bones or arteries is not known.

How much vitamin K2 should I take?

There is no separate recommendation for K2: the adequate intake for all vitamin K is 90 mcg a day for women and 120 mcg for men, and most diets meet it (NIH ODS). The main bone trial of MK-7 used 180 mcg a day (Knapen et al., 2013).

Does vitamin K2 remove calcium from arteries?

No trial has shown that. In one 2-year trial MK-7 slowed the rise in coronary calcium scores, another found no effect on aortic valve calcium, and neither showed fewer heart attacks (Vossen et al., 2026; Diederichsen et al., 2022).

Do I need K2 with vitamin D?

Not necessarily: vitamin D and vitamin K each have their own intake recommendations (NIH ODS; NIH ODS). Our vitamin D3 and K2 guide explains when a combination makes sense and why to skip K2 if you take a blood thinner.

The Bottom Line

Vitamin K2 is a real nutrient with a real drug interaction. If you take warfarin or a similar blood thinner, do not take K2 unless your doctor agrees. For everyone else, most diets already meet the adequate intake, and the evidence that K2 supplements protect bones or arteries is limited and mixed.

If you still choose K2, the main bone trial of MK-7 used 180 mcg a day (Knapen et al., 2013), and no upper limit has been set for vitamin K (NIH ODS).

If you only remember one thing: vitamin K2 and warfarin do not mix without medical supervision.

Scientific References

  1. Theuwissen et al., 2013. Effect of low-dose supplements of menaquinone-7 (vitamin K2 ) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. J Thromb Haemost.
  2. Schurgers et al., 2007. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood.
  3. Sato et al., 2012. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J.
  4. Cockayne et al., 2006. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med.
  5. Knapen et al., 2013. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int.
  6. Mott et al., 2019. Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials. Osteoporos Int.
  7. Diederichsen et al., 2022. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. Circulation.
  8. Vossen et al., 2026. Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial. JAMA Cardiol.
  9. Li et al., 2023. Vitamin K supplementation and vascular calcification: a systematic review and meta-analysis of randomized controlled trials. Front Nutr.
  10. NIH Office of Dietary Supplements: Vitamin K, Health Professional Fact Sheet (updated October 22, 2026).
  11. NIH Office of Dietary Supplements: Vitamin D, Health Professional Fact Sheet (updated June 27, 2025).